Publications

Epidemiology and Surveillance
  • Progress report on the elimination of human onchocerciasis, 2017–2018. Weekly Epidemiological Record. 2018; 93(47): 633–48.
  • Sauerbrey M, Rakers LJ, Richards FO Jr. Progress toward elimination of onchocerciasis in the Americas. Int Health. 2018; 10: i71–i78.
  • Cantey PT, Roy SL, Boakye D, Mwingira U, Ottesen EA, Hopkins AD, Sodahlon YK. Transitioning from river blindness control to elimination: steps toward stopping treatment. Int Health. 2018; 10: i7–i13.
  • Zarroug IMA, Hashim K, El Mubark WA, Shumo ZAI, Salih KAM, El Nojomi NAA, Awad HA, Aziz N, Katabarwa M, Hassan HK, Unnasch TR, Mackenzie CD, Richards F, Higazi TB. The first confirmed elimination of an onchocerciasis focus in Africa: Abu Hamed, Sudan. Am J Trop Med Hyg. 2016; 95(5): 1037–40.

Back To Top

Disease
  • Showler AJ, Kubofcik J, Ricciardi A, Nutman TB. Differences in the clinical and laboratory features of imported onchocerciasis in endemic individuals and temporary residents. Am J Trop Med Hyg. 2019; 100(5): 1216–22.
  • Murdoch ME, Asuzu MC, Hagan M, et al. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol. 2002;96:283–96.
  • Hopkins A. Onchocerciasis then and now: achievements, priorities and challenges. Community Eye Health. 2017; 30(100): 92–5.

Back To Top

Diagnosis
  • Udall DN. Recent updates on onchocerciasis: diagnosis and treatment. Clin Infect Dis 2007: 44: 53-60.
  • Stingl P. Onchocerciasis: developments in diagnosis, treatment and control. Int J Dermatol 2009; 48: 393-396.
  • Showler AJ, Nutman TB. Imported onchocerciasis in migrants and travelers. Curr Opin Infect Dis. 2018;31(5):393–8.
  • Unnasch TR, Golden A, Cama V, Cantey PT. Diagnostics for onchocerciasis in the era of elimination. Int Health. 2018; 10: i20–i26.

Back To Top

Treatment
  • Basáñez MG, Pion SDS, Boakes E, J.A. Filipe, Churcher TS, Boussinesq M. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8:310–22.
  • Walker M, Pion SDS, Fang H, Gardon J, Kamgno J, Basáñez MG, Boussinesq M. Macrofilaricidal efficacy of repeated doses of ivermectin for the treatment of river blindness. Clin Infect Dis. 2017;65:2026–34.
  • Abegunde AT, Ahuja RM, Okafor NJ. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis. Cochrane Database Syst Rev. 2016;(1): CD011146. doi: 10.1002/14651858.CD011146.pub2.
  • Hoerauf H, Mand S, Adjei O, et al. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet. 2001;357:1415–6.
  • Hoerauf A, Specht S, Marfo-Debrekyei Y, Buttner M, Debrah AY, Mand S, Batsa L, Brattig N, Konadu P, Bandi C, Fimmers R, Adjei O, Buttner DW. Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Parasitol Res. 2009; 104:437–47.

Back To Top

Prevention & Control

Back To Top

Page last reviewed: September 19, 2019